{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,20]],"date-time":"2026-11-20T02:14:26Z","timestamp":1795140866942,"version":"4.10.3"},"reference-count":43,"publisher":"Walter de Gruyter GmbH","issue":"2","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,6,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Introduction<\/jats:title>\n                    <jats:p>Antimicrobial resistance (AMR) poses a global threat to public and animal health, and its progression is closely linked to the use of antimicrobials in veterinary medicine. In Europe, programmes such as the European Surveillance of Veterinary Antimicrobial Consumption (ESVAC) and subsequently European Sales and Use of Antimicrobials for Veterinary Medicine (ESUAvet) monitor and attempt to reduce the consumption of antimicrobials in food-producing animals. The study analyses the trends in the volume and sales structure of veterinary antimicrobials in Poland in 2011\u20132023 and compares them with data reported by other European countries.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Material and Methods<\/jats:title>\n                    <jats:p>The analysis was based on data from ESVAC reports (2011\u20132022) and the first ESUAvet report (2023), as well as data from the European Medicines Agency\u2019s Antimicrobial Sales and Use Platform. The data were evaluated by antimicrobial class, pharmaceutical form and Antimicrobial Advice Ad-hoc Expert Group (AMEG) categories, the latter being A (avoid), B (restrict), C (caution) and D (prudence).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>While total sales of veterinary antimicrobials in Europe decreased by 48.0% between 2011 and 2023, in Poland they increased by 19.5% during the same period. In Poland, the predominance of AMEG category D antimicrobials persisted, although their share declined from 79% to 64% with a concurrent increase in sales of category C. The sales structure shifted significantly towards oral solutions, replacing oral powders. Penicillins became the dominant antimicrobial group in the later years, while tetracyclines sales declined.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>The Polish trend diverges from the European one of reducing veterinary antimicrobial consumption. To align with EU reduction targets, Poland should strengthen antimicrobial stewardship, tighten prescription control and promote preventive measures such as vaccination and higher biosecurity within the One Health framework.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.2478\/jvetres-2026-0032","type":"journal-article","created":{"date-parts":[[2026,7,6]],"date-time":"2026-07-06T08:05:52Z","timestamp":1783325152000},"page":"233-244","source":"Crossref","is-referenced-by-count":1,"title":["Analysis of sales of antimicrobials used in veterinary medicine in Poland compared to Europe"],"prefix":"10.2478","volume":"70","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1337-9526","authenticated-orcid":false,"given":"Ilona","family":"Barbara Materek","sequence":"first","affiliation":[{"name":"Department of Veterinary Medicinal Products Control, National Veterinary Research Institute , Pu\u0142awy , Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3120-915X","authenticated-orcid":false,"given":"Katarzyna","family":"Pasik","sequence":"additional","affiliation":[{"name":"Department of Veterinary Medicinal Products Control, National Veterinary Research Institute , Pu\u0142awy , Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9933-3395","authenticated-orcid":false,"given":"Ewa","family":"Borzym","sequence":"additional","affiliation":[{"name":"Department of Veterinary Medicinal Products Control, National Veterinary Research Institute , Pu\u0142awy , Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"374","published-online":{"date-parts":[[2026,6,30]]},"reference":[{"key":"2026081913023003341_j_jvetres-2026-0032_ref_001","unstructured":"Agence f\u00e9d\u00e9rale des m\u00e9dicaments et des produits de sant\u00e9\/Federaal Agentschap voor Geneesmiddelen en Gezondheidsproducten (Belgium): Belgian Veterinary Surveillance on Antimicrobial Consumption National Report on Sales and Use of Antibacterial Veterinary Medicinal Products 2024 (BelVet-SAC 2024). AFMPS\/FAGG, Brussels, Belgium, 2025, https:\/\/www.fagg-afmps.be\/sites\/default\/files\/BVS-report_2024_final.pdf."},{"key":"2026081913023003341_j_jvetres-2026-0032_ref_002","doi-asserted-by":"crossref","unstructured":"Bedford C., Galotta M.L., Oikonomou G., de Yaniz G., Nardello M., S\u00e1nchez Bruni S., Davies P.: A mixed method approach to analysing patterns and drivers of antibiotic use and resistance in beef farms in Argentina. Front Vet Sci 2024, 11, 1454032, doi: 10.3389\/fvets.2024.1454032.","DOI":"10.3389\/fvets.2024.1454032"},{"key":"2026081913023003341_j_jvetres-2026-0032_ref_003","unstructured":"Danmarks Tekniske Universitet National Food Institute, Statens Serum Institut: DANMAP 2022: Use of antimicrobial agents and occurrence of antimicrobial resistance in bacteria from food animals, food and humans in Denmark. DTU National Food Institute, Kongens Lyngby, Statens Serum Institut, Copenhagen, Denmark, https:\/\/www.danmap.org\/."},{"key":"2026081913023003341_j_jvetres-2026-0032_ref_004","doi-asserted-by":"crossref","unstructured":"European Centre for Disease Prevention and Control, European Food Safety Authority, European Medicines Agency: Fourth joint interagency report on integrated analysis of consumption of antimicrobial agents and occurrence of antimicrobial resistance in bacteria from humans and food-producing animals in the EU\/EEA. ECDC, Stockholm, Sweden, EFSA, Parma, Italy, EMA, Amsterdam, the Netherlands, 2024, doi: 10.2903\/j.efsa.2024.8589.","DOI":"10.2903\/j.efsa.2024.8589"},{"key":"2026081913023003341_j_jvetres-2026-0032_ref_005","unstructured":"European Commission: Commission Delegated Regulation (EU) 2021\/578 of 29 January 2021 supplementing Regulation (EU) 2019\/6 of the European Parliament and of the Council with regard to requirements for the collection of data on the volume of sales and on the use of antimicrobial medicinal products in animals. OJEU L 64, 123, 09\/04\/2021, 7\u201320, https:\/\/eurlex.europa.eu\/legal-content\/PL\/TXT\/?uri=CELEX:32021R0578."},{"key":"2026081913023003341_j_jvetres-2026-0032_ref_006","unstructured":"European Commission: Commission Implementing Regulation (EU) 2022\/209 of 16 February 2022 establishing the format of the data to be collected and reported in order to determine the volume of sales and the use of antimicrobial medicinal products in animals in accordance with Regulation (EU) 2019\/6 of the European Parliament and of the Council. OJEU L 65, 35, 17\/02\/2022, 7\u201316, https:\/\/eur-lex.europa.eu\/legal-content\/EN\/TXT\/PDF\/?uri=CELEX:32022R0209."},{"key":"2026081913023003341_j_jvetres-2026-0032_ref_007","unstructured":"European Medicine Agency: Antimicrobial Sales and Use (ASU) Platform. EMA, Amsterdam, the Netherlands, https:\/\/www.ema.europa.eu\/en\/veterinary-regulatory-overview\/antimicrobial-resistance-veterinary-medicine\/antimicrobial-sales-use-platform."},{"key":"2026081913023003341_j_jvetres-2026-0032_ref_008","unstructured":"European Medicines Agency: EMA\/27839\/2024 Antimicrobial Sales and Use (ASU) Platform User Guide. User guide for National Competent Authority users. EMA, Amsterdam, the Netherlands, 2025, https:\/\/www.ema.europa.eu\/en\/documents\/other\/antimicrobial-sales-and-use-asu-platform-user-guide_en.pdf."},{"key":"2026081913023003341_j_jvetres-2026-0032_ref_009","unstructured":"European Medicines Agency: EMA\/CVMP\/CHMP\/682198\/2017-Rev1 Categorisation of antibiotics in the European Union. Answer to the request from the European Commission for updating the scientific advice on the impact on public health and animal health ofthe use of antibiotics in animals. EMA, Amsterdam, the Netherlands, 2025, https:\/\/www.ema.europa.eu\/en\/documents\/report\/categorisation-antibiotics-european-union-answer-request-european-commission-updating-scientific-advice-impact-public-health-animal-health-use-antibiotics-animals_en.pdf."},{"key":"2026081913023003341_j_jvetres-2026-0032_ref_010","unstructured":"European Medicines Agency: EMACVMP\/ESUAVET\/80289\/2025 European Sales and Use of Antimicrobials for veterinary medicine (ESUAvet). Annual surveillance report for 2023. EMA, Amsterdam, the Netherlands, 2025, https:\/\/www.ema.europa.eu\/en\/documents\/report\/european-sales-use-antimicrobials-veterinary-medicine-annual-surveillance-report-2023_en.pdf."},{"key":"2026081913023003341_j_jvetres-2026-0032_ref_011","unstructured":"European Medicines Agency: EMA\/299538\/2023 Sales of veterinary antimicrobial agents in 31 European countries in 2022. Trends from 2010 to 2022. Thirteenth ESVAC report. EMA, Amsterdam, the Netherlands, 2023, https:\/\/www.ema.europa.eu\/en\/documents\/report\/sales-veterinary-antimicrobial-agents-31-european-countries-2022-trends-2010-2022-thirteenth-esvac-report_en.pdf."},{"key":"2026081913023003341_j_jvetres-2026-0032_ref_012","unstructured":"European Medicines Agency: EMA\/795956\/2022 Sales of veterinary antimicrobial agents in 31 European countries in 2021. Trends from 2010 to 2021. Twelfth ESVAC report. EMA, Amsterdam, the Netherlands, 2022, https:\/\/www.ema.europa.eu\/en\/documents\/report\/sales-veterinary-antimicrobial-agents-31-european-countries-2021-trends-2010-2021-twelfh-esvac-report_en.pdf."},{"key":"2026081913023003341_j_jvetres-2026-0032_ref_013","unstructured":"European Medicines Agency: EMA\/58183\/2021 Sales of veterinary antimicrobial agents in 31 European countries in 2019 and 2020. Trends from 2010 to 2020. Eleventh ESVAC report. EMA, Amsterdam, the Netherlands, 2021, https:\/\/www.ema.europa.eu\/en\/documents\/report\/sales-veterinary-antimicrobial-agents-31-european-countries-2019-and-2020-trends-2010-2020-eleventh-esvac-report_en.pdf."},{"key":"2026081913023003341_j_jvetres-2026-0032_ref_014","unstructured":"European Medicines Agency: EMA\/24309\/2020 Sales of veterinary antimicrobial agents in 31 European countries in 2018. Trends from 2010 to 2018. Tenth ESVAC report. EMA, Amsterdam, the Netherlands, 2020, doi: 10.2809\/195073, https:\/\/www.ema.europa.eu\/en\/documents\/report\/sales-veterinary-antimicrobial-agents-31-european-countries-2018-trends-2010-2018-tenth-esvac-report_en.pdf."},{"key":"2026081913023003341_j_jvetres-2026-0032_ref_015","unstructured":"European Medicines Agency: EMA\/294674\/2019 Sales of veterinary antimicrobial agents in 31 European countries in 2017. Trends from 2010 to 2017. Ninth ESVAC report. EMA, Amsterdam, the Netherlands, 2019, https:\/\/www.ema.europa.eu\/en\/documents\/report\/sales-veterinary-antimicrobial-agents-31-european-countries-2017-ninth-esvac-report_en.pdf."},{"key":"2026081913023003341_j_jvetres-2026-0032_ref_016","unstructured":"European Medicines Agency: EMA\/275982\/2018 Sales of veterinary antimicrobial agents in 30 European countries in 2016. Trends from 2010 to 2016. Eighth ESVAC report. EMA, London, UK, 2018, doi: 10.2809\/807372, https:\/\/www.ema.europa.eu\/en\/documents\/report\/sales-veterinary-antimicrobial-agents-30-european-countries-2016-trends-2010-2016-eighth-esvac-report_en.pdf."},{"key":"2026081913023003341_j_jvetres-2026-0032_ref_017","unstructured":"European Medicines Agency: EMA\/184855\/2017 Sales of veterinary antimicrobial agents in 30 European countries in 2015. Trends from 2010 to 2015. Seventh ESVAC report. EMA, London, UK, 2017, doi: 10.2809\/283486, https:\/\/www.ema.europa.eu\/en\/documents\/report\/seventh-esvac-report-sales-veterinary-antimicrobial-agents-30-european-countries-2015_en.pdf."},{"key":"2026081913023003341_j_jvetres-2026-0032_ref_018","unstructured":"European Medicines Agency: EMA\/61769\/2016 Sales of veterinary antimicrobial agents in 29 European countries in 2014. Sixth ESVAC report. EMA, London, UK, 2016, doi: 10.2809\/676974, https:\/\/www.ema.europa.eu\/en\/documents\/report\/sixth-esvac-report-sales-veterinary-antimicrobial-agents-29-european-countries-2014_en.pdf."},{"key":"2026081913023003341_j_jvetres-2026-0032_ref_019","unstructured":"European Medicines Agency: EMA\/387934\/2015 Sales of veterinary antimicrobial agents in 26 EU\/EEA countries in 2013. Fifth ESVAC report. EMA, London, UK, 2015, doi: 10.2809\/140479, https:\/\/www.ema.europa.eu\/en\/documents\/report\/fifth-esvac-report-sales-veterinary-antimicrobial-agents-26-european-unioneuropean-economic-area-countries-2013_en.pdf."},{"key":"2026081913023003341_j_jvetres-2026-0032_ref_020","unstructured":"European Medicines Agency: EMA\/333921\/2014 Sales of veterinary antimicrobial agents in 26 EU\/EEA countries in 2012. Fourth ESVAC report. EMA, London, UK, 2014, doi: 10.2809\/10553, https:\/\/www.ema.europa.eu\/en\/documents\/report\/sales-veterinary-antimicrobial-agents-26-european-union-european-economic-area-countries-2012-fourth-european-surveillance-veterinary-antimicrobial-consumption-report_en.pdf."},{"key":"2026081913023003341_j_jvetres-2026-0032_ref_021","unstructured":"European Medicines Agency: EMA\/236501\/2013 Sales of veterinary antimicrobial agents in 25 EU\/EEA countries in 2011. Third ESVAC report. EMA, London, UK, 2013, https:\/\/www.ema.europa.eu\/en\/documents\/report\/sales-veterinary-antimicrobial-agents-25-european-union-european-economic-area-countries-2011-third-european-surveillance-veterinary-antimicrobial-consumption-report_en.pdf."},{"key":"2026081913023003341_j_jvetres-2026-0032_ref_022","unstructured":"European Parliament and the Council of the European Union: Regulation (EU) 2019\/6 of the European Parliament and of the Council of 11 December 2018 on veterinary medicinal products and repealing Directive 2001\/82\/EC. OJEU L 2019, 62, 4, 07\/01\/2019, 43\u2013167."},{"key":"2026081913023003341_j_jvetres-2026-0032_ref_023","unstructured":"General Veterinary Inspectorate (Poland): List of pharmaceutical wholesalers of veterinary medicinal products (in Polish). G\u0142\u00f3wny Inspektorat Weterynarii, Warsaw, Poland, 2026, https:\/\/www.wetgiw.gov.pl\/handel-eksport-import\/listy-podmiotow."},{"key":"2026081913023003341_j_jvetres-2026-0032_ref_024","unstructured":"Government of the Republic of Poland: Rozporz\u0105dzenie Ministra Rolnictwa i Rozwoju Wsi z dnia 16 grudnia 2016 r. w sprawie przekazywania danych w kwartalnych raportach dotycz\u0105cych wielko\u015bci obrotu produktami leczniczymi weterynaryjnymi (Regulation of the Minister of Agriculture and Rural Development of 16 December 2016 on the submission of data in quarterly reports on the volume of trade in veterinary medicinal products \u2013 in Polish). Dz U 2016, poz 2160 (Official Journal of Laws 2016, item 2160), https:\/\/isap.sejm.gov.pl\/isap.nsf\/download.xsp\/WDU20160002160\/O\/D20162160.pdf."},{"key":"2026081913023003341_j_jvetres-2026-0032_ref_025","doi-asserted-by":"crossref","unstructured":"Herman K., Nowaczek A., Urban-Chmiel R., Pyzik E., Dec M.: Reduction of antibiotic usage in animal treatment in the EU based on European Surveillance of Veterinary Antimicrobial Consumption reports (in Polish). Med Weter 2024, 80, 477\u2013483, doi: 10.21521\/mw.6919.","DOI":"10.21521\/mw.6919"},{"key":"2026081913023003341_j_jvetres-2026-0032_ref_026","doi-asserted-by":"crossref","unstructured":"Hunt D., Kates O.S.: A brief history of antimicrobial resistance. AMA J Ethics 2024, 26, 408\u2013417, doi: 10.1001\/amajethics.2024.408.","DOI":"10.1001\/amajethics.2024.408"},{"key":"2026081913023003341_j_jvetres-2026-0032_ref_027","doi-asserted-by":"crossref","unstructured":"Hutchings M.I., Truman A.W., Wilkinson B.: Antibiotics: past, present and future. Curr Opin Microbiol 2019, 51, 72\u201380, doi: 10.1016\/j.mib.2019.10.008.","DOI":"10.1016\/j.mib.2019.10.008"},{"key":"2026081913023003341_j_jvetres-2026-0032_ref_028","doi-asserted-by":"crossref","unstructured":"K\u00f6per L.M., Bode C., Bender A., Reimer I., Heberer T., Wallmann J.: Eight years of sales surveillance of antimicrobials for veterinary use in Germany \u2013 What are the perceptions? PLoS One, 2020, 15, e0237459, doi: 10.1371\/journal.pone.0237459.","DOI":"10.1371\/journal.pone.0237459"},{"key":"2026081913023003341_j_jvetres-2026-0032_ref_029","doi-asserted-by":"crossref","unstructured":"Leit\u00e3o M., Sarragu\u00e7a J., Taghouti M., Monteiro A.C.G.: Challenges and obstacles for veterinary antimicrobial agents\u2019 data collection for an \u201cOne Health\u201d European goal to address antimicrobial resistances. Med Sci Forum 2024, 24, 15, doi: 10.3390\/ECA2023-16430.","DOI":"10.3390\/ECA2023-16430"},{"key":"2026081913023003341_j_jvetres-2026-0032_ref_030","doi-asserted-by":"crossref","unstructured":"Merle R., Meyer-K\u00fchling B.: Sales data as a measure of antibiotics usage: Concepts, examples and discussion of influencing factors. Vet Med Sci 2019, 6, 154\u2013163, doi: 10.1002\/vms3.205.","DOI":"10.1002\/vms3.205"},{"key":"2026081913023003341_j_jvetres-2026-0032_ref_031","unstructured":"Minist\u00e8re de l\u2019Agriculture et de l\u2019Alimentation of the Republic of France: \u00c9coantibio2, The French National Plan for the Reduction of the Risks of Antimicrobial Resistance in Veterinary Medicine 2017\u20132021. https:\/\/faolex.fao.org\/docs\/pdf\/fra196378ENG.pdf."},{"key":"2026081913023003341_j_jvetres-2026-0032_ref_032","doi-asserted-by":"crossref","unstructured":"Muska A., Pilvere I., Upite I., Muska K., Nipers A.: Assessing European Union Member States\u2019 progress toward antimicrobial sales reduction targets under the European Green Deal: a comparative policy and performance analysis. Vet World 2025, 18, 2746\u20132760, doi: 10.14202\/vetworld.2025.2746-2760.","DOI":"10.14202\/vetworld.2025.2746-2760"},{"key":"2026081913023003341_j_jvetres-2026-0032_ref_033","unstructured":"Norwegian Institute of Public Health World Health Organization Collaborating Centre for Drug Statistics Methodology: ATC Vet Codes. NIPH WHO Collaborating Centre for Drug Statistics Methodology, Oslo, Norway, 2024, https:\/\/atcddd.fhi.no\/atcvet\/."},{"key":"2026081913023003341_j_jvetres-2026-0032_ref_034","unstructured":"Norwegian Veterinary Institute: NORM-VET \u2013 the monitoring program for antimicrobial resistance in the veterinary and food production sectors. Norwegian Veterinary Institute, \u00c5s, Norway, 2026, https:\/\/www.vetinst.no\/en\/surveillance-programmes\/norm-norm-vet-report."},{"key":"2026081913023003341_j_jvetres-2026-0032_ref_035","unstructured":"Osek J., Wieczorek K.: Sales of antimicrobial agents used in veterinary medicine in European countries in 2020 (in Polish). \u017bycie Wet 2022, 97, 265\u2013267."},{"key":"2026081913023003341_j_jvetres-2026-0032_ref_036","doi-asserted-by":"crossref","unstructured":"Schmerold I., van Geijlswijk I., Gehring R.: European regulations on the use of antibiotics in veterinary medicine. Eur J Pharm Sci 2023, 189, 106473, doi: 10.1016\/j.ejps.2023.106473.","DOI":"10.1016\/j.ejps.2023.106473"},{"key":"2026081913023003341_j_jvetres-2026-0032_ref_037","doi-asserted-by":"crossref","unstructured":"Silva A.C., Nogueira P.J., Paiva J.-A.: Determinants of antimicrobial resistance among the different European countries: More than human and animal antimicrobial consumption. Antibiotics 2021, 10, 834, doi: 10.3390\/antibiotics10070834.","DOI":"10.3390\/antibiotics10070834"},{"key":"2026081913023003341_j_jvetres-2026-0032_ref_038","doi-asserted-by":"crossref","unstructured":"Simjee S., Ippolito G.: European regulations on prevention use of antimicrobials from January 2022. Revista Braz J Vet Med 2022, 44, e000822, doi: 10.29374\/2527-2179.bjvm000822.","DOI":"10.29374\/2527-2179.bjvm000822"},{"key":"2026081913023003341_j_jvetres-2026-0032_ref_039","unstructured":"Swedish Veterinary Agency: Swedres-Svarm Reports, Sales of antibiotics and occurrence of antibiotic resistance in Sweden. SVA, Uppsala, Sweden, 2024, https:\/\/www.sva.se\/media\/cegdew24\/swedres-svarm-2023.pdf."},{"key":"2026081913023003341_j_jvetres-2026-0032_ref_040","unstructured":"Trading Economics Database: Poland \u2013 Production of meat: poultry. Trading Economics, New York, NY, USA, https:\/\/tradingeconomics.com\/poland\/production-of-meat-poultry-eurostat-data.html."},{"key":"2026081913023003341_j_jvetres-2026-0032_ref_041","doi-asserted-by":"crossref","unstructured":"Urban-Chmiel R., Marek A., St\u0119pie\u0144-Py\u015bniak D., Wieczorek K., Dec M., Nowaczek A., Osek J.: Antibiotic resistance in bacteria \u2013 a review. Antibiotics 2022, 11, 1079\u20131119, doi: 10.3390\/antibiotics11081079.","DOI":"10.3390\/antibiotics11081079"},{"key":"2026081913023003341_j_jvetres-2026-0032_ref_042","doi-asserted-by":"crossref","unstructured":"Velazquez-Meza M.E., Galarde-L\u00f3pez M., Carrillo-Quir\u00f3z B., Alpuche-Aranda C.M.: Antimicrobial resistance: One Health approach. Vet World 2022, 15, 743\u2013749, doi: 10.14202\/vetworld.2022.743-749.","DOI":"10.14202\/vetworld.2022.743-749"},{"key":"2026081913023003341_j_jvetres-2026-0032_ref_043","unstructured":"Zenkner M.J.: Prewencja weterynaryjna w fermach kr\u00f3w mlecznych (Preventive veterinary measures in dairy cattle farms \u2013 in Polish). \u017bycie Wet 2021, 96, 251\u2013267."}],"container-title":["Journal of Veterinary Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/reference-global.com\/pdf\/10.2478\/jvetres-2026-0032","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T13:03:23Z","timestamp":1787144603000},"score":1,"resource":{"primary":{"URL":"https:\/\/reference-global.com\/article\/10.2478\/jvetres-2026-0032"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,1]]},"references-count":43,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2026,6,30]]},"published-print":{"date-parts":[[2026,6,1]]}},"alternative-id":["10.2478\/jvetres-2026-0032"],"URL":"https:\/\/doi.org\/10.2478\/jvetres-2026-0032","relation":{},"ISSN":["2450-8608"],"issn-type":[{"value":"2450-8608","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,1]]}}}